Dyspnoea-12 and Multidimensional Dyspnea Profile: Systematic Review of Use and Properties.
Williams MT, Lewthwaite H, Paquet C, Johnston K, Olsson M, Belo LF, Pitta F, Morelot-Panzini C, Ekström M.
J Pain Symptom Manage. 2022 Jan;63(1):e75-e87. doi: 10.1016/j.jpainsymman.2021.06.023. Epub 2021 Jul 15.
Pulmonary rehabilitation for interstitial lung disease.
Dowman L, Hill CJ, May A, Holland AE.
Cochrane Database Syst Rev. 2021 Feb 1;2(2):CD006322. doi: 10.1002/14651858.CD006322.pub4.
[Differentiation of dyspnea in patients with asthma and lung sarcoidosis].
Płusa T.
Pol Merkur Lekarski. 2018 Mar 27;44(261):110-112.
Practical guide to cardiopulmonary exercise testing in adults.
Glaab T, Taube C.
Respir Res. 2022 Jan 12;23(1):9. doi: 10.1186/s12931-021-01895-6.
Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research.
Banzett RB, O'Donnell CR, Guilfoyle TE, Parshall MB, Schwartzstein RM, Meek PM, Gracely RH, Lansing RW.
Eur Respir J. 2015 Jun;45(6):1681-91. doi: 10.1183/09031936.00038914. Epub 2015 Mar 18.
Dyspnoea: Pathophysiology and a clinical approach.
Coccia CB, Palkowski GH, Schweitzer B, Motsohi T, Ntusi NA.
S Afr Med J. 2016 Jan;106(1):32-6. doi: 10.7196/samj.2016.v106i1.10324.
Breathlessness.
Gibson PG.
Respirology. 2023 Feb;28(2):187-188. doi: 10.1111/resp.14426. Epub 2022 Nov 30.
The role of invasive cardiopulmonary exercise testing in patients with unexplained dyspnea: a systemic review.
Behrooz L, Barillas-Lara M, Fattouh M, Loubeau B, Ibrahim M.
Acta Cardiol. 2023 Sep;78(7):754-760. doi: 10.1080/00015385.2022.2141434. Epub 2022 Nov 8.
[Dyspnoea].
Makowska AM, Jorstad HT, van den Brink RBA, van den Aardweg JG.
Ned Tijdschr Geneeskd. 2022 Aug 9;166:D6922.
Diagnostic value of MR-proANP for heart failure in patients with acute dyspnea:a meta-analysis.
Chen Y, Wen Z, Peng L, Liu X, Luo Y, Wu B, Li S.
Acta Cardiol. 2020 Feb;75(1):68-74. doi: 10.1080/00015385.2018.1550887. Epub 2019 Feb 8.
